Option chain shows key data for Virpax Pharmaceuticals's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Virpax Pharmaceuticals.

Virpax Pharmaceuticals (NASDAQ:VRPX) Stock, Option Chain

Virpax Pharmaceuticals

Virpax Pharmaceuticals Inc is a preclinical stage biopharmaceutical company. The company is focused on developing pharmaceutical product candidates for pain management. Its product portfolio includes Topical metered-dose spray; Liposomal in Hydrogel encapsulation; and Enkephalin Intranasal spray.

What The Future Might Hold

Equities

Government

Market Summary

News

Futures

Treasuries

Economics

Pre-Market Outlook

Markets

Analyst Ratings

DELL

GTLS

NVDA

PMAX

RKLB

RPID

SOUN

VRPX

U.S. stock futures rose on Friday following Thursday&#39;s sell-off. Futures advanced except the small-cap gauge Russell 2000.

US Stocks Likely To Open Higher Following A Sell-Off, &#39;This Choppy Start To 2025 Isn&#39;t Abnormal. Don&#39;t Panic,&#39; Says Expert Highlighting Seasonal Weakness In The First Quarter After Elections

Stethoscope,Laying,On,Medicine,White,Pills,Money,With,Rx,Prescription

Biotech

Health Care

Movers

Trading Ideas

General

PCRX

Virpax completed a U.S. Army-backed Probudur study, showing potential for prolonged pain relief and reduced opioid use in surgical recovery.

Penny Stock Virpax Pharmaceuticals Surges On US Army-Performed Preclinical Study For Pain Candidate

airbnb shutter

ABNB

BLAC

BSLK

CNSP

FFIE

INFA

JRSH

MBRX

MYNA

PCLA

SLSR

STAI

STVN

ZCAR

Why Airbnb Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket

Virpax Pharmaceuticals, Inc. - Common Stock

Virpax Pharmaceuticals Inc

Press Releases

Spartan Capital Securities, LLC Serves as Sole Placement Agent in Virpax Pharmaceuticals, Inc.'s $5.0 Million Public Offering

Virpax Announces Agreement with the U.S. Department of Health and Human Services for the Developmental Extension for NES100 Towards IND for Acute and Chronic Non-Cancer Pain Alternative

Virpax Announces Positive Results for the Swine Model Dose Range Finding Study for Probudur™

Virpax Pharmaceuticals, Inc. Announces Pricing of $6 Million Public Offering of Common Stock and Pre-Funded Warrants

Virpax Pharmaceuticals, Inc. Announces Closing of $6.0 Million Public Offering of Common Stock and Pre-Funded Warrants

Spartan Capital Securities Serves as Sole Placement Agent in Virpax Pharmaceuticals' $6 Million Follow-On Offering

Virpax's Matthew Barnes to Present at Outsourcing in Clinical Trials Conference

Virpax Confirms Positive Results with US Army with Probudur™ for Combat Care Study

Virpax Reports Positive Results in Human Study for its Molecular Envelope Technology

Stocks Under $1: PMAX PRSO ARBB KAVL to Watch in March 2025 – More Stocks Inside

ADTX

AIBT

ARBB

CSDX

KAVL

PRSO

SIGL

TSXV:YGT

YGTFF

Adial Pharmaceuticals, Inc - Common Stock

Adial Pharmaceuticals

Addex Therapeutics Ltd - American Depositary Shares

Addex Therapeutics

Akanda

Artelo Biosciences

Avenue Therapeutics

Aytu BioPharma

Biofrontera

CNS Pharma

China Pharma Holding

Enveric Biosciences

Evoke Pharma

Eyenovia

NovaBay Pharmaceuticals, Inc. Common Stock

NovaBay Pharmaceuticals

Processa Pharmaceuticals, Inc. - Common Stock

Processa Pharma

Purple Biotech Ltd. - American Depositary Shares

Purple Biotech

Petros Pharmaceuticals, Inc. - Common Stock

Petros Pharma

Redhill Biopharma Ltd. - American Depositary Shares

Redhill Biopharma

Relmada Therapeutics, Inc. - Common Stock

Relmada Therapeutics

SenesTech

Sonoma Pharmaceuticals, Inc. - Common Stock

Sonoma Pharmaceuticals

China SXT Pharmaceuticals, Inc. - Common Stock

China SXT Pharmaceuticals

60 Degrees Pharmaceuticals, Inc. - Common Stock

60 Degrees

Traws Pharma

Titan Pharmaceuticals, Inc. - Common Stock

Titan Pharma

cbdMD

Comments

Virpax Pharmaceuticals

Virpax Pharmaceuticals (VRPX) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga